Washington [US], November 16 (ANI): The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 per cent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from th
Washington DC [US], November 10 (ANI): The US Food and Drug Administration (FDA) has approved an emergency use authorisation (EUA) for American pharmaceutical company Eli Lilly's experimental COVID-19 antibody treatment called 'bamlanivimab' for non-hospitalised patients with mild-to-moderat
Washington D.C, Jul 21 (ANI): Adding a novel monoclonal antibody therapy to traditional chemotherapy can help make people more likely to survive advanced sarcoma, a lethal soft-tissue cancer, by nearly a year, suggests a recent study.